Search

everythinglearnresearchcommunity

for

Search:↓

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Topical retinoids effectively improve photodamaged skin.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Platelet preparations generally show positive effects on wound healing and facial rejuvenation, but more thorough research is needed to confirm their effectiveness.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Some systemic treatments work for nail psoriasis but can have serious side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Neurosteroids show promise for treating epilepsy and more research is needed.